Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00297284 · ClinicalTrials.gov registry record · NA
Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil
A NA study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00297284 is a NA study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 20 participants.
The verdict
NCT00297284, a NA study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is being conducted in order to determine if the FDA-approved drug Modafinil can improve cognitive function in patients with lupus. Modafinil is currently being used to treat excessive sleepiness caused by certain sleep disorders. It has also been shown to improve attention and concentration in some people who don't have lupus or sleep disorders. This study hopes to determine if Modafinil can be used safely and effectively in lupus patients, and improve their quality of life. No medications currently exist for the treatment of lupus-associated cognitive dysfunction.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00297284
The ClinicalTrials.gov registry entry for NCT00297284 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT00297284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00297284 about?
NCT00297284 is a clinical study titled "Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil". This study is being conducted in order to determine if the FDA-approved drug Modafinil can improve cognitive function in patients with lupus. Modafinil is currently being used to treat excessive sleepiness caused by certain sleep disorders. It has also been shown to improve attention and concentrati...
What is the current status of trial NCT00297284?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2006-02. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00297284?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00297284?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.